Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) with stable deep molecular response (DMR) discontinuing dasatinib (DASFREE) Meeting Abstract


Authors: Shah, N. P.; Garcia-Gutierrez, J. V.; Jimenez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gomez-Casares, M. T.; Pane, F.; Nicolini, F. E.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H.
Abstract Title: Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) with stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
Meeting Title: 58th Annual Scientific Meeting of the British Society for Haematology
Keywords: dasatinib; chronic myeloid leukemia; tyrosine; kinase inhibitor; treatment-free remission
Journal Title: British Journal of Haematology
Volume: 181
Issue: Suppl. 1
Meeting Dates: 2018 Apr 16-18
Meeting Location: Liverpool, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2018-04-01
Start Page: 5
Language: English
ACCESSION: WOS:000430117900002
PROVIDER: wos
PUBMED: 29658101
DOI: 10.1111/bjh.15226
Notes: Meeting Abstract: BSH18-OR-001 -- 58th Annual Scientific Meeting of the British-Society-for-Haematology -- APR 16-18, 2018 -- Liverpool, ENGLAND -- 1 -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro